Numerous important pharmaceuticals and nutraceuticals originate from plant specialized metabolites, most of which are synthesized complex biosynthetic pathways. The elucidation of these pathways is critical for the applicable uses of these compounds. Although the rapid progress of the omics technology has revolutionized the identification of candidate genes involved in these pathways, the functional characterization of these genes remains a major bottleneck.
View Article and Find Full Text PDF